Patents Assigned to CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
  • Patent number: 10308654
    Abstract: Disclosed are a preparation method for a kinase inhibitor and a use thereof. The kinase inhibitor is a compound represented by formula (I) wherein the groups are defined as described in the description. The compound of formula (I) has a kinase inhibitory activity and therefore can be used for the preparation of medicines for treating kinase activity-related diseases.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: June 4, 2019
    Assignee: CHANGZHOU LONGTHERA PHARMACEUTICALS INC.
    Inventors: Peng Cheng, Wenjie Cao